# ARMP (Armata Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Armata Pharmaceuticals, Inc. reported $84.48M in total assets and a net loss of $110.6M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ARMP
- Markdown: https://convexityos.com/fundamentals/ARMP.md
- SEC CIK: 0000921114
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000921114&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$40.30M | Operating profit |
| Net Income | FY 2025 | -$110.6M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.77 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$26.86M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $18.32M | Total debt: $30.11M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $23.72M | $34.43M | $33.77M | $35.02M | $20.02M | $14.44M | $9.82M | $8.37M | $2.88M | $5.68M |
| Total Operating Expenses | $41.54M | $47.61M | $45.42M | $42.45M | $28.30M | $22.41M | $19.75M | $17.66M | $16.27M | $23.64M |
| **Operating Income** | -$36.63M | -$42.44M | -$40.89M | -$36.95M | -$23.82M | -$21.59M | -$19.75M | -$17.66M | -$16.16M | -$23.38M |
| **EBITDA** | -$35.10M | -$41.11M | -$39.92M | -$36.05M | -$22.65M | -$20.47M | -$18.40M | -$16.28M | -$15.78M | -$23.01M |
| Interest Income | -- | -- | $179K | $29K | $5.0K | $28K | $96K | $245K | -- | -- |
| Interest Expense | -- | -- | $2.63M | $0 | $64K | $628K | $931K | $1.01M | -- | $6.0K |
| Income Before Tax | -$173.8M | -$18.92M | -$69.05M | -$37K | -$23.16M | -$22.18M | -$19.48M | -$16.70M | -$14.14M | -$19.39M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | -$328K | -$1.30M | -$556K |
| **Net Income** | -$173.8M | -$18.92M | -$69.05M | -$36.92M | -$23.16M | -$22.18M | -$19.48M | -$16.70M | -$12.84M | -$18.84M |
| Basic EPS | -$4.80 | -$0.52 | -$1.91 | -$1.08 | -$0.96 | -$1.35 | -$2.49 | -$50.28 | -$1,395.17 | -$17,123.82 |
| **Diluted EPS** | -$4.80 | -$0.89 | -$1.91 | -$1.08 | -$0.96 | -$1.35 | -$2.55 | -$50.28 | -$1,513.17 | -$17,123.82 |
| Basic Shares Outstanding | 36.2M | 36.2M | 36.1M | 34.3M | 24.1M | 16.4M | 7.8M | 332.2K | 9.2K | 1.4K |
| Diluted Shares Outstanding | 36.2M | 59.1M | 36.1M | 34.3M | 24.1M | 16.4M | 8.0M | 332.2K | 9.5K | 1.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $6.83M | $7.59M | $6.11M | $6.07M | $5.82M | $6.39M | $5.43M | $8.45M |
| Total Operating Expenses | $10.55M | $12.82M | $9.57M | $14.91M | $8.94M | $9.01M | $8.68M | $11.77M |
| **Operating Income** | -$7.38M | -$10.31M | -$8.79M | -$13.82M | -$7.78M | -$6.84M | -$8.19M | -$10.54M |
| **EBITDA** | -$6.78M | -$9.81M | -$8.33M | -$13.40M | -$7.41M | -$6.48M | -$7.81M | -$10.16M |
| Income Tax Expense | $0 | $0 | $0 | -- | $0 | $0 | $0 | -- |
| **Net Income** | $54.86M | $74.14M | -$115.3M | -$124.3M | -$26.68M | -$16.30M | -$6.53M | $2.60M |
| Basic EPS | $1.15 | $2.02 | -$3.16 | -- | -$0.74 | -$0.45 | -$0.18 | -- |
| **Diluted EPS** | -$0.24 | -$0.27 | -$3.16 | -- | -$0.74 | -$0.45 | -$0.20 | -- |
| Basic Shares Outstanding | 37.2M | 36.7M | 36.5M | -- | 36.2M | 36.2M | 36.2M | -- |
| Diluted Shares Outstanding | 62.7M | 62.0M | 36.5M | -- | 36.2M | 36.2M | 59.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.69M | $9.29M | $13.52M | $14.85M | $10.29M | $9.65M | $6.03M | $9.66M | $5.13M | $5.13M |
| **Cash & Short-Term Investments** | $8.69M | $9.29M | $13.52M | $14.85M | $10.29M | $9.65M | $6.03M | $9.66M | $5.13M | $5.13M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $12K |
| Other Current Assets | $472K | $744K | $3.36M | $8.53M | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $10.67M | $11.31M | $19.15M | $27.05M | $14.99M | $10.85M | $6.66M | $10.36M | $5.38M | $6.31M |
| Property, Plant & Equipment, Net | $12.19M | $13.24M | $12.56M | $3.62M | $2.22M | $2.05M | $2.19M | $3.25M | $816K | $1.07M |
| Goodwill | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M | -- | -- | -- |
| Intangible Assets | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M | $2.73M | $4.66M | $10.46M |
| Other Non-Current Assets | $973K | $975K | $2.47M | $2.43M | $1.75M | $887K | $135K | $136K | -- | -- |
| **Total Non-Current Assets** | $66.21M | $75.13M | $79.21M | $68.79M | $54.77M | $28.67M | $18.80M | $4.18M | $5.75M | $11.84M |
| **Total Assets** | $76.88M | $86.44M | $98.36M | $95.83M | $69.77M | $39.52M | $25.45M | $14.54M | $11.14M | $18.15M |
| Accounts Payable | $921K | $766K | $1.58M | $1.68M | $1.14M | $956K | $547K | $415K | $578K | $1.06M |
| Other Current Liabilities | $487K | $529K | $523K | -- | -- | -- | -- | -- | -- | $185K |
| **Total Current Liabilities** | $8.95M | $48.25M | $16.46M | $24.87M | $4.81M | $6.71M | $4.88M | $2.03M | $1.97M | $3.54M |
| **Total Non-Current Liabilities** | $286.5M | $86.21M | $114.0M | $34.88M | $39.56M | $13.95M | $5.98M | $4.82M | $1.44M | $4.89M |
| **Total Liabilities** | $295.5M | $134.5M | $130.4M | $59.75M | $44.37M | $20.66M | $10.86M | $6.85M | $3.41M | $8.43M |
| **Total Debt (incl. Leases)** | $31.10M | $32.12M | $38.06M | $48.81M | $37.99M | $12.43M | $2.86M | -- | -- | -- |
| Common Stock | $364K | $362K | $361K | $361K | $271K | $187K | $99K | $51K | $95K | $16K |
| Retained Earnings | -$501.5M | -$327.7M | -$308.8M | -$239.8M | -$202.9M | -$179.7M | -$157.5M | -$138.0M | -$394.2M | -$381.4M |
| **Total Stockholders' Equity** | -$218.6M | -$48.02M | -$32.06M | $36.08M | $25.40M | $18.86M | $14.59M | $7.69M | $24.34M | $9.72M |
| Total Equity | -$218.6M | -$48.02M | -$32.06M | $36.08M | $25.40M | $18.86M | $14.59M | $7.69M | $24.34M | $9.72M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $18.32M | $23.95M | $4.75M | $8.69M | $14.76M | $4.33M | $11.69M | $9.29M |
| **Cash & Short-Term Investments** | $18.32M | $23.95M | $4.75M | $8.69M | $14.76M | $4.33M | $11.69M | $9.29M |
| Other Current Assets | $3.21M | $2.53M | $47K | $472K | $759K | $2.17M | $238K | $744K |
| **Total Current Assets** | $22.60M | $27.16M | $5.95M | $10.67M | $16.93M | $7.52M | $13.17M | $11.31M |
| Property, Plant & Equipment, Net | $10.80M | $11.23M | $11.78M | $12.19M | $12.56M | $12.66M | $12.88M | $13.24M |
| Goodwill | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M | $3.49M |
| Intangible Assets | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M | $10.26M |
| Other Non-Current Assets | $836K | $813K | $813K | $973K | $973K | $973K | $975K | $975K |
| **Total Non-Current Assets** | $61.88M | $62.79M | $63.85M | $66.21M | $72.59M | $73.27M | $74.08M | $75.13M |
| **Total Assets** | $84.48M | $89.95M | $69.80M | $76.88M | $89.52M | $80.79M | $87.25M | $86.44M |
| Accounts Payable | $587K | $1.19M | $660K | $921K | $1.28M | $965K | $981K | $766K |
| Other Current Liabilities | $459K | $195K | $372K | $487K | $503K | $137K | $337K | $529K |
| **Total Current Liabilities** | $186.8M | $250.2M | $9.23M | $8.95M | $139.9M | $120.1M | $110.5M | $48.25M |
| **Total Non-Current Liabilities** | $71.83M | $70.92M | $372.2M | $286.5M | $45.15M | $30.21M | $30.49M | $86.21M |
| **Total Liabilities** | $258.6M | $321.1M | $381.4M | $295.5M | $185.1M | $150.3M | $141.0M | $134.5M |
| **Total Debt (incl. Leases)** | $30.11M | $30.45M | $30.78M | $31.10M | $31.36M | $31.62M | $31.88M | $32.12M |
| Common Stock | $372K | $371K | $366K | $364K | $362K | $362K | $362K | $362K |
| Retained Earnings | -$487.9M | -$542.7M | -$616.9M | -$501.5M | -$377.2M | -$350.6M | -$334.3M | -$327.7M |
| **Total Stockholders' Equity** | -$174.1M | -$231.2M | -$311.6M | -$218.6M | -$95.59M | -$69.50M | -$53.78M | -$48.02M |
| Total Equity | -$174.1M | -$231.2M | -$311.6M | -$218.6M | -$95.59M | -$69.50M | -$53.78M | -$48.02M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$173.8M | -$18.92M | -$69.05M | -$36.92M | -$23.16M | -$22.18M | -$19.48M | -$16.70M | -$12.84M | -$18.84M |
| Depreciation & Amortization | $1.53M | $1.32M | $972K | $892K | $1.17M | $1.11M | $1.35M | $1.38M | $374K | $369K |
| Stock-Based Compensation | $2.61M | $2.89M | $938K | $3.10M | $2.88M | $3.48M | $4.27M | $46K | $700K | $2.00M |
| Change in Receivables | -- | -- | -- | -- | -- | -$467K | -- | -- | -- | $100K |
| **Operating Cash Flow** | -$25.76M | -$37.55M | -$47.42M | -$32.48M | -$23.57M | -$18.27M | -$15.58M | -$10.63M | -$9.19M | -$10.61M |
| Capital Expenditure | -$542K | -$1.88M | -$8.14M | -$2.21M | -$1.30M | -$824K | -$224K | -$875K | -$58K | -$279K |
| **Free Cash Flow** | -$26.30M | -$39.43M | -$55.57M | -$34.69M | -$24.88M | -$19.09M | -$15.81M | -$11.50M | -$9.25M | -$10.88M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -$3.39M | -- | -- |
| **Investing Cash Flow** | -$542K | -$1.88M | -$8.13M | -$2.21M | -$1.30M | -$824K | $2.88M | $8.81M | -$58K | -$279K |
| Common Stock Issued | -- | -- | -- | $44.39M | $26.32M | $22.89M | $9.97M | $12.25M | $9.35M | $7.57M |
| Dividends Paid | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$80K |
| **Financing Cash Flow** | $25.61M | $34.96M | $53.99M | $44.02M | $25.52M | $23.21M | $8.97M | $12.45M | $8.67M | $7.23M |
| **Net Change in Cash** | -$693K | -$4.47M | -$1.57M | $9.32M | $639K | $4.12M | -$3.73M | -$1.81M | -$579K | -$3.66M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $54.86M | $74.14M | -$115.3M | -$124.3M | -$26.68M | -$16.30M | -$6.53M | $2.60M |
| Depreciation & Amortization | $600K | $500K | $457K | $418K | $370K | $366K | $377K | $380K |
| Stock-Based Compensation | $2.22M | $3.39M | $1.07M | $632K | $622K | $575K | $781K | $354K |
| **Operating Cash Flow** | -$5.52M | -$8.67M | -$5.78M | -$6.67M | -$4.30M | -$7.21M | -$7.58M | -$7.93M |
| Capital Expenditure | -$91K | -$17K | -$63K | -$52K | -$242K | -$149K | -$99K | $77K |
| **Free Cash Flow** | -$5.61M | -$8.68M | -$5.84M | -$6.73M | -$4.54M | -$7.36M | -$7.68M | -$7.85M |
| **Investing Cash Flow** | -$91K | -$17K | -$63K | -$52K | -$242K | -$149K | -$99K | $77K |
| **Financing Cash Flow** | -$28K | $27.88M | $641K | $658K | $14.97M | $0 | $9.99M | $0 |
| **Net Change in Cash** | -$5.63M | $19.20M | -$5.20M | -$6.07M | $10.43M | -$7.36M | $2.31M | -$7.85M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -102.3% | -91.2% | -117.6% | -133.5% | -217.1% | -52.7% | -193.7% |
| Return on Assets (ROA) | -226.1% | -21.9% | -70.2% | -38.5% | -33.2% | -56.1% | -76.5% | -114.8% | -115.3% | -103.8% |
| Current Ratio | 1.19x | 0.23x | 1.16x | 1.09x | 3.11x | 1.62x | 1.36x | 5.10x | 2.74x | 1.78x |
| Quick Ratio | 0.97x | 0.19x | 0.82x | 0.60x | 2.14x | 1.44x | 1.24x | 4.76x | 2.61x | 1.45x |
| Debt to Equity | -- | -- | -- | 1.35x | 1.50x | 0.66x | 0.20x | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -100.1% | -- | -- | -- |
| 10Y Net Income / Share Growth | -- | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -131.0% | -213.6% | -404.9% | -226.1% | -52.4% | -31.8% | -0.5% | -21.9% |
| Current Ratio | 0.12x | 0.11x | 0.64x | 1.19x | 0.12x | 0.06x | 0.12x | 0.23x |
| Quick Ratio | 0.10x | 0.10x | 0.52x | 0.97x | 0.11x | 0.04x | 0.11x | 0.19x |
| **Net Income Growth (YoY)** | -- | -- | -- | -4880.7% | -- | -281.3% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -280.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
